Showing results (121-130 of 205) with videos related to
Sort By:
Pageof 21
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1972
Dopamine- -hydroxylase activity in mouse neuroblastoma tumors and in cell culturesB Anagnoste, L S Freedman, M Goldstein, et al.Cancer Treatment Reports|February 1, 1983
Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant gliomaS B Green, D P Byar, M D Walker, et al.Journal of the National Cancer Institute|November 21, 1990
Validation of intermediate end points in cancer researchA Schatzkin, L S Freedman, M H Schiffman, et al.Life Sciences|August 9, 1982
Cardiac beta-receptor variation in rat strains selectively bred for differences in susceptibility to stressB Liang, C E Dunlap, L S Freedman, et al.American Journal of Epidemiology|July 15, 1997
Breast cancer clusters in the northeast United States: a geographic analysisM Kulldorff, E J Feuer, B A Miller, et al.Journal of Neurosurgery|February 1, 1976
Effect of dopamine-beta-hydroxylase inhibition on cerebral vasospasm in the catA F Battista, E S Flamm, M Goldstein, et al.Pharmacology, Biochemistry, and Behavior|September 1, 1977
Reversal of cycloheximide-induced amnesia by adrenergic receptor stimulationD Quartermain, L S Freedman, C Y Botwinick, et al.Statistics in Medicine|September 30, 1994
A unified method for monitoring and analysing controlled trialsJ Grossman, M K Parmar, D J Spiegelhalter, et al.Pharmacology, Biochemistry, and Behavior|May 1, 1977
Some characteristics of amnesia induced by FLA-63 an inhibitor of dopamine beta hydroxylaseC Y Botwinick, D Quartermain, L S Freedman, et al.The New England Journal of Medicine|July 8, 1976
Randomized clinical trials. Perspectives on some recent ideasD P Byar, R M Simon, W T Friedewald, et al.Pageof 21